Education
About Us
Working with TipRanks
Follow Us
Sutro Biopharma Inc (STRO)
NASDAQ:STRO
Luveltamab Tazevibulin
Acute Myeloid Leukemia (Aml)
Phase I/II
Terminated
Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML
Nov 02, 2024
―
Luveltamab Tazevibulin
Lung Cancer, Lung Cancer, Non-Small Cell, Lung Cancer Metastatic, Lung Cancer, Nonsmall Cell, Lung Cancer Non-Small Cell Stage Iiib, Lung Cancer Non-Small Cell Stage Iv
Phase II
Withdrawn
Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer
Aug 12, 2024
―
Gemcitabine, Paclitaxel, Topotecan, Pegylated Liposomal Doxorubicin, Luveltamab Tazevibulin, Pegfilgrastim
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Ovarian Cancer, Platinum-Resistant Ovarian Cancer, Primary Peritoneal Cancer
Phase II/III
Terminated
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1
May 12, 2023
―
Bevacizumab, Stro-002
Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer
Phase I
Terminated
A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer
Dec 19, 2021
―
Stro-002
Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Ovarian Cancer, Ovarian Carcinoma, Endometrial Cancer, Ovary Cancer, Endometrioid Adenocarcinoma
Phase I
Completed
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers
Nov 13, 2018
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Sutro Biopharma Inc (STRO) have in its pipeline
STRO is currently developing the following drugs: Luveltamab Tazevibulin, Luveltamab Tazevibulin, Gemcitabine, Paclitaxel, Topotecan, Pegylated Liposomal Doxorubicin, Luveltamab Tazevibulin, Pegfilgrastim. These drug candidates are in various stages of clinical development as the company works toward FDA approval.